Siegfried Holding AG (SFZN)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Siegfried Holding AG (SFZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012234
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. The company also offers development and production services for finished dosage forms including sterile filling. Siegfried serves principally companies operating in pharmaceutical industry. It has production facilities in the USA, Switzerland, Malta, China, Germany and France. The company offers its products in USA Europe and other countries. Siegfried is headquartered in Zofingen, Switzerland.

Siegfried Holding AG (SFZN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Debt Offering 10
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 10
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 11
Siegfried Holding Raises USD61.33 Million in Bonds Offering 12
Acquisition 13
Siegfried Acquires Hameln Pharma for USD62 Million 13
Siegfried Acquires Alliance Medical Products For US$58 Million 15
Siegfried Holding AG – Key Competitors 16
Siegfried Holding AG – Key Employees 17
Siegfried Holding AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Financial Announcements 20
Aug 23, 2017: Siegfried Reports Higher Profit and Increased Margin for First Six Months 20
Mar 14, 2017: Siegfried with Jump in Sales in 2016 21
Aug 18, 2016: Siegfried with Jump in Sales 22
Mar 22, 2016: Siegfried with Record Sales in 2015 24
Corporate Communications 26
Mar 21, 2017: Siegfried Group: Management Changes 26
Mar 09, 2016: Siegfried: Ulla Schmidt and Martin Schmid recommended for nomination to the Board of Directors 27
Legal and Regulatory 28
Jun 27, 2016: Chinese authorities issued operating approval to Siegfried Nantong 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Siegfried Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Siegfried Holding AG, Deals By Therapy Area, 2011 to YTD 2017 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 10
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 11
Siegfried Holding Raises USD61.33 Million in Bonds Offering 12
Siegfried Acquires Hameln Pharma for USD62 Million 13
Siegfried Acquires Alliance Medical Products For US$58 Million 15
Siegfried Holding AG, Key Competitors 16
Siegfried Holding AG, Key Employees 17
Siegfried Holding AG, Subsidiaries 18

★海外企業調査レポート[Siegfried Holding AG (SFZN)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nohmi Bosai Ltd:企業の戦略・SWOT・財務情報
    Nohmi Bosai Ltd - Strategy, SWOT and Corporate Finance Report Summary Nohmi Bosai Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Want Want China Holdings Limited:企業の戦略・SWOT・財務情報
    Want Want China Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Want Want China Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Comstock Resources Inc (CRK):企業の財務・戦略的SWOT分析
    Summary Comstock Resources Inc (Comstock) is an oil and gas company. It acquires, develops, explores and produces oil and natural gas properties. The company provides oil and gas operations such as Eagle ford Shale, Haynesville Shale and Bakken Shale in North Dakota and Montana; and North Louisiana, …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Qatar Electricity & Water Company QSC:発電所・企業SWOT分析
    Qatar Electricity & Water Company QSC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Inflection Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Inflection Biosciences Ltd (Inflection Biosciences) is a drug development company focused on discovery and development of small molecule therapeutics for the treatment of cancer. The company’s pipeline products include dual mechanism kinase inhibitors and pim kinase inhibitors including IBL- …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PLC SPA (IIN):電力:M&Aディール及び事業提携情報
    Summary PLC SPA (PLC Group) formerly Industria e Innovazione S.p.A, is a provider of design, installation, and maintenance services for electrical infrastructures and renewable energy plants. The company’s service offerings include engineering, procurement, and construction (EPC); manufacturing and …
  • Faron Pharmaceuticals Oy (FARN):医療機器:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • DNO ASA (DNO):企業の財務・戦略的SWOT分析
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It operates its oil and gas producing assets lo …
  • Inchcape plc (INCH):企業の財務・戦略的SWOT分析
    Inchcape plc (INCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Inhibitor Therapeutics Inc (INTI):企業の財務・戦略的SWOT分析
    Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Chicago Bridge & Iron Company NV (CBI):石油・ガス:M&Aディール及び事業提携情報
    Summary Chicago Bridge & Iron Company NV (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental services …
  • Tyco International plc:企業のM&A・事業提携・投資動向
    Tyco International plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tyco International plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Owens Corning:企業の戦略・SWOT・財務情報
    Owens Corning - Strategy, SWOT and Corporate Finance Report Summary Owens Corning - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sinopharm Group Co Limited:企業の戦略・SWOT・財務分析
    Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tanabe Research Laboratories USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tanabe Research Laboratories USA Inc (TRL), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a healthcare research center that discovers biological drugs. The center conducts research on metabolics, inflammation and immunology. Its products are used for the therapy of serious diseases with …
  • Tokmanni Group Oyj (TOKMAN):企業の財務・戦略的SWOT分析
    Tokmanni Group Oyj (TOKMAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • TDK Corporation (6762):企業の財務・戦略的SWOT分析
    TDK Corporation (6762) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Siluria Technologies Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Siluria Technologies Inc (Siluria) engaged in producing fuels and chemicals from natural gas and low value byproducts. Its products include modus - olefins to gasoline, and gemini - natural gas to ethylene. The company also involved in catalytic process to convert natural gas into liquid fue …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆